Subcutaneous Dihydrotestosterone (DHT) Treatment: Mouse Model of Polycystic Ovary Syndrome (PCOS)
Published: April 30, 2023
Disclosures
The authors have nothing to disclose.
Tags
Cite This Article
Subcutaneous Dihydrotestosterone (DHT) Treatment: Mouse Model of Polycystic Ovary Syndrome (PCOS). J. Vis. Exp. (Pending Publication), e20778, doi: (2023).